Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+48Malignant Bladder Neoplasm+24Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+16Malignant Salivary Gland Neop…+16Malignant Prostate Neoplasm+12Malignant Mesothelioma+8Malignant Anal Neoplasm+4Malignant Kidney Neoplasm+4Malignant Liver Neoplasm+4Malignant Testicular Neoplasm+4Malignant Lung Neoplasm0Malignant Rectal Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+48100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21301
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
88
activityPercentile
40

ranking row 2605568

2▲3Malignant Bladder Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12064
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
72
activityPercentile
48

ranking row 2605570

2▲1Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3054
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2605569

4=Cutaneous Melanoma+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5375
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2605571

5▲3Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12503
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2605572

5▲9Malignant Pancreatic Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
24279
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
92
activityPercentile
76

ranking row 2605573

5▲2Malignant Salivary Gland Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
723
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
28
activityPercentile
12

ranking row 2605574

8▲10Malignant Prostate Neoplasm+1272Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
32707
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2605575

9=Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1806
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2605576

10▲6Malignant Anal Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
605
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
24
activityPercentile
20

ranking row 2605580

10▲7Malignant Kidney Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9541
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56

ranking row 2605577

10▲12Malignant Liver Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
18636
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
84
activityPercentile
80

ranking row 2605578

10▲2Malignant Testicular Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
461
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
8
activityPercentile
4

ranking row 2605579

14▲9Malignant Lung Neoplasm048Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
72949
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2605581

14▲1Malignant Rectal Neoplasm048Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6742
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
52
activityPercentile
52

ranking row 2605583

14▲10Malignant Thyroid Gland Neoplasm048Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
928
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2605582

17▲4Malignant Hypopharyngeal Neoplasm-436Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
362
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
4
activityPercentile
8

ranking row 2605584

17▲3Malignant Penile Neoplasm-436Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
346
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
4

ranking row 2605585

19▲7Leukemia-828Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13775
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
88

ranking row 2605586

19▲7Malignant Central Nervous System Neoplasm-828Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10214
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
64
activityPercentile
72

ranking row 2605587

21▲7Multiple Myeloma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6875
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56
activityPercentile
68

ranking row 2605588

22▲8Hodgkin Lymphoma-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
602
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
20
activityPercentile
36

ranking row 2605589

22▲7Malignant Gastric Neoplasm-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6663
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
48
activityPercentile
64

ranking row 2605590

24▲7Non-Hodgkin Lymphoma-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11590
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
68
activityPercentile
92

ranking row 2605591

25▲7Malignant Nasopharyngeal Neoplasm-324Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
469
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
12
activityPercentile
44

ranking row 2605592

26▲10Malignant Breast Neoplasm-800Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
490
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
16
activityPercentile
96

ranking row 2605593

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash e77465c8b9b745a0ff83260c